Bicycle Therapeutics PLC
NASDAQ:BCYC

Watchlist Manager
Bicycle Therapeutics PLC Logo
Bicycle Therapeutics PLC
NASDAQ:BCYC
Watchlist
Price: 21.6 USD -0.51% Market Closed
Updated: May 22, 2024

Bicycle Therapeutics PLC
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bicycle Therapeutics PLC
Selling, General & Administrative Peer Comparison

Comparables:
CNTA
EXAI
AUTL
IMCR
GNS

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Bicycle Therapeutics PLC
NASDAQ:BCYC
Selling, General & Administrative
-$62.3m
CAGR 3-Years
-24%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Selling, General & Administrative
-$53.7m
CAGR 3-Years
-261%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Selling, General & Administrative
-£41.2m
CAGR 3-Years
-58%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Selling, General & Administrative
-$54.9m
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Selling, General & Administrative
-£144.5m
CAGR 3-Years
-47%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Selling, General & Administrative
-£7.6m
CAGR 3-Years
-1%
CAGR 5-Years
-10%
CAGR 10-Years
-9%

See Also

What is Bicycle Therapeutics PLC's Selling, General & Administrative?
Selling, General & Administrative
-62.3m USD

Based on the financial report for Mar 31, 2024, Bicycle Therapeutics PLC's Selling, General & Administrative amounts to -62.3m USD.

What is Bicycle Therapeutics PLC's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-46%

Over the last year, the Selling, General & Administrative growth was -35%. The average annual Selling, General & Administrative growth rates for Bicycle Therapeutics PLC have been -24% over the past three years , -46% over the past five years .